Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking α vβ5 integrin

Experimental Cell Research

Volumn 294, Issue 1, 2004, Pages 172-184

  Koh, Jeong Tae ^a   Kook, Hyun ^a   Kee, Hae Jin ^a   Seo, Young Woo ^b   Jeong, Byung Chul ^a   Lee, Ji Hee ^a   Kim, Mi Young ^a   Yoon, Kyung Chul ^a   Jung, Shin ^a   Kim, Kyung Keun ^a,c  

^a Chonnam National University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Antiproliferative action; Brain specific angiogenesis inhibitor 1 (BAI1); Endothelial cells; Neuron specific gene; v 5 integrin

Indexed keywords

ALPHAVBETA5 INTEGRIN; ANGIOGENESIS INHIBITOR; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 1; CD36 ANTIGEN; INTEGRIN; MEMBRANE PROTEIN; PROTEIN ANTIBODY; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAIN TISSUE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; EMBRYO; ENDOTHELIUM CELL; FLUORESCENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; UMBILICAL VEIN;

EID: 10744227896     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2003.11.008     Document Type: Article

References (33)

1. Aplin A.E., Howe A., Alahari S.K., Juliano R.L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50:1998;197-263.
2. v integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103:1999;1227-1230.
3. Koh J.T., Lee Z.H., Ahn K.Y., Kim J.K., Bae C.S., Kim H.-H., Kee H.J., Kim K.K. Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein. Mol. Brain Res. 87:2001;223-237.
4. 3 integrin and inhibits angiogenesis. J. Biol. Chem. 276:2001;31959-31968.
5. v integrins. Science. 270:1995;1500-1502.
6. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1994;1157-1164.
7. Varner J.A. The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis. EXS. 79:1997;361-390.
8. 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9764-9769.
9. Erdreich-Epstein A., Shimada H., Groshen S., Liu M., Metelitsa L.S., Kim K.S., Stins M.F., Seeger R.C., Durden D.L. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res. 60:2001;712-721.
10. Guo N., Krutzsch H.C., Inman J.K., Roberts D.D. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res. 57:1997;1735-1742.
11. Streit M., Riccardi L., Velasco P., Brown L.F., Hawighorst T., Bornstein P., Detmar M. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14888-14893.
12. Streit M., Velasco P., Brown L.F., Skobe M., Richard L., Riccardi L., Lawler J., Detmar M. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am. J. Pathol. 155:1999;441-452.
13. Lawler J. The functions of thrombospondin-1 and -2. Curr. Opin. Cell Biol. 12:2000;634-640.
14. Nishimori H., Shiratsuchi T., Urano T., Kimura Y., Kiyono K., Tatsumi K., Yoshida S., Ono M., Kuwano M., Nakamura Y., Tokino T. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene. 15:1997;2145-2150.
15. Shiratsuchi T., Nishimori H., Ichise H., Nakamura Y., Tokino T. Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1). Cytogenet. Cell Genet. 79:1997;103-108.
16. Kee H.J., Koh J.T., Kim M.Y., Ahn K.Y., Kim J.K., Bae C.S., Park S.S., Kim K.K. Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis. J. Cereb. Blood Flow Metab. 22:2002;1054-1067.
17. Stefan C.J., Blumer K.J. The third cytoplasmic loop of a yeast G-protein-coupled receptor controls pathway activation, ligand discrimination, and receptor internalization. Mol. Cell. Biol. 14:1994;3339-3349.
18. Tolsma S.S., Volpert O.V., Good D.J., Frazier W.A., Polverini P.J., Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122:1993;497-511.
19. 5 subunits contain a metal ion-dependent adhesion site-like motif but lack an I domain. J. Biol. Chem. 272:1997;14236-14243.
20. WAF1/CIP1- dependent manner: its potential utility in local gene therapy of tumor. Cell Growth Differ. 12:2001;243-254.
21. Lee J.H., Seo Y.-W., Park S.R., Kim Y.J., Kim K.K. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res. 63:2003;7247-7255.
22. Dawson D.W., Pearce S.F., Zhong R., Silverstein R.L., Frazier W.A., Bouck N.P. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138:1997;707-717.
23. Jimenez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., Bouck N. Signals leading to a apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6:2000;41-48.
24. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130:1995;503-506.
25. Plate K.H. Mechanisms of angiogenesis in the brain. J. Neuropathol. Exp. Neurol. 58:1999;313-320.
26. Van Meir E.G., Polverini P.J., Chazin V.R., Su Huang H.J., de Tribolet N., Cavenee W.K. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet. 8:1994;171-176.
27. Fredriksson R., Gloriam D.E.I., Höglund P.J., Lagerström M.C., Schiöith H.B. There exist at least 30 human G-protein-coupled receptors with long Ser/Thr-rich N-termini. Biochem. Biophys. Res. Commun. 301:2003;725-734.
28. Krasnoperov V., Lu Y., Buryanovsky L., Neubert T., Ichtchenko K., Petrenko A. Post-translational proteolytic processing of the calcium-independent receptor of α-Latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. J. Biol. Chem. 277:2002;46518-46526.
29. Asch A.S., Liu I., Briccetti F.M., Barnwell J.W., Kwakye-Berko F., Dokun A., Goldberger J., Pernambuco M. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science. 262:1993;1436-1440.
30. Swerlick R.A., Lee K.H., Wick T.M., Lawley T.J. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J. Immunol. 148:1992;78-83.
31. 5 monoclonal antibodies. J. Cell Sci. 105:1993;101-111.
32. Bader B.L., Rayburn H., Crowley D., Hynes R.O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell. 95:1998;507-519.
33. 3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103:1999;229-238.